+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Symproic - Drug Insight, 2019

  • ID: 4807942
  • Report
  • July 2019
  • Region: Global
  • DelveInsight
1 of 2
Symproic - Drug Insight, 2019 report provides comprehensive information of the drug, Symproic. It includes drugs overview, Symproic mechanism of action, clinical trials, regulatory milestones, deals & Symproic's partnerships. It further provides Symproic`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted Symproic sales till 2021. The report also throws light on Symproic market competition and emerging therapies in the same space as Symproic. Symproic SWOT analysis is also featured. * Depending on information availability.


Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by the research team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
  • A comprehensive Symproic overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Symproic Patent information in United States (US) and Europe (EU) has been highlighted
  • Symproic API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Symproic sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Symproic operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Symproic SWOT analysis
Reasons to Buy
  • Establish a comprehensive understanding of the drug, Symproic
  • Access to Symproic API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Symproic patents for the major markets- US and EU
  • Understand current and future Symproic`s growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Symproic
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Symproic
  • Identify opportunities in the same area as with Symproic SWOT analysis
Note: Product cover images may vary from those shown
2 of 2
1. Report Introduction

2. Symproic - Overview
  • Symproic Product Description
  • Symproic Route of Synthesis
  • Symproic Mechanism of Action
  • Symproic Pharmacology
  • Symproic Pharmacodynamics
  • Symproic Pharmacokinetics
  • Symproic Adverse Reactions
  • Symproic Clinical Trials
  • Symproic Regulatory Milestones
  • Symproic Development Activities
3. Global API Manufacturers
  • United States
  • Europe
  • China
  • India
4. Product Details
  • United States
  • Europe
5. Symproic Global Sales Assessment
  • Symproic Sales Global(Historical)
  • Symproic Sales Global(Forecasted)
6. Symproic Patent Details

7. Symproic Market Competition

8. Symproic Emerging Therapies
8.1. Drug name: Company name
  • Product Description
  • Research & Development
  • Product Development Activities
9. Symproic SWOT Analysis
  • Appendix
  • Methodology
  • Consulting Services
  • About the Publisher
List of Tables
Table 1: Symproic, Description
Table 2: API Manufacturers Region wise
Table 3: API Manufacturers for United States
Table 4: API Manufacturers for Europe
Table 5: API Manufacturers for China
Table 6: API Manufacturers for India
Table 7: Symproic Product Details, United States
Table 8: Symproic Product Details, Europe
Table 9: Symproic, Historical Global Sales till 2017 (in million USD)
Table 10: Symproic, Forecasted Global Sales from 2019-2021 (in million USD)
Table 11: Patent Details: Symproic
Table 12: Symproic Major Competitors
Table 13: Emerging Therapies

List of Figures
Figure 1: Symproic
Figure 2: Symproic, Historical Global Sales till 2017 (in million USD)
Figure 3: Symproic, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 4: Patent Details: Symproic
Figure 5: API Manufacturers Region wise
Note: Product cover images may vary from those shown
3 of 2